Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-21-000145

Options or other derivatives

  • SVP and CFO acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lamothe Jeffrey G. SVP and CFO 2021-01-29 Grant or award · Stock Option (right to buy) +16,500 16,500 D
Lamothe Jeffrey G. SVP and CFO 2021-01-29 Grant or award · Restricted Stock Unit +5,500 5,500 D
Loading xslF345X03/lamothe.xml…